Mirum Pharmaceuticals, Inc.

MIRM

NASDAQ

Healthcare

Biotechnology

Foster City, CA, US334 employeesmirumpharma.com

$94.24

-0.38(-0.40%)

52W $38.39 – $108.62

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Revenue breakdown: Product (74.7%), Livmarli (17.2%), Bile Acid Medicines (7.7%).

$4.7BMkt Cap

$521MRev TTM

-$23MNI TTM

-192.2xP/E TTM

What Changed Recently

Financial Results

Feb 24, 2026

Results of Operations and Financial Condition. On February 25, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) issued a press release providing a corporate up

View filing →

Asset Acquisition+3 More

Jan 25, 2026

Completion of Acquisition or Disposition of Assets. On January 23, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) completed the previously announced acquisit

View filing →

Financial Results

Jan 11, 2026

Results of Operations and Financial Condition. On January 12, 2026, Mirum Pharmaceuticals, Inc. (the “Company”) issued a press release announcing, among other t

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Product74.7%($3.1B)

Livmarli17.2%($715M)

Bile Acid Medicines7.7%($321M)

License And Other Revenue0.4%($16M)

Revenue by Geography

US79.3%($822M)

Non Us20.7%($214M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
BLTEBelite Bio, Inc	$169.68	+1.45%	$6.7B	-65.3
PRAXPraxis Precision Medicine...	$310.78	-2.66%	$6.6B	-21.8
LGNDLigand Pharmaceuticals, I...	$199.05	-0.29%	$4.0B	31.8
ACADACADIA Pharmaceuticals In...	$22.18	-0.65%	$3.8B	9.1
DYNDyne Therapeutics, Inc.	$18.86	+4.20%	$3.1B	-5.1
TLXTelix Pharmaceuticals Lim...	$9.14	-1.08%	$3.1B	-390.0
TVTXTravere Therapeutics, Inc...	$30.46	-3.06%	$2.8B	-49.9
ADMAADMA Biologics, Inc.	$9.15	+0.44%	$2.2B	22.0

Company Profile

CIK0001759425

ISINUS6047491013

CUSIP604749101

Phone650 667 4085

Address950 Tower Lane, Foster City, CA, 94404, US

SEC EDGAR